Hamid Borghei‐Razavi

809 citations
51 papers · 452 indexed · h-index 13

Hamid Borghei‐Razavi

49 papers receiving 450 citations

Peers

Hamid Borghei‐Razavi
Comparison fields: 5 of 59
  • Neurology 184
  • Genetics 116
  • Epidemiology 241
  • Surgery 168
  • Endocrinology, Diabetes and Metabolism 59
Replace Chang-Ki Hong with:
Chang-Ki Hong South Korea
Anne-Laure Bernat France
Hun Ho Park South Korea
Michele Bailo Italy
Hirotaka Hasegawa Japan
Hamid Borghei-Razavi United States
Toshiaki Kodera Japan
Carmine Antonio Donofrio Italy
Fabio Roberti United States
Fuminari Komatsu Japan
Hamid Borghei‐Razavi relative to Chang-Ki Hong South Korea Chang-Ki Hong's profile →
Citations per field
00.5×1.5×
Chang-Ki Hong · 1×
Citations per year

Countries citing papers authored by Hamid Borghei‐Razavi

Since Specialization
Citations

This map shows the geographic impact of Hamid Borghei‐Razavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Borghei‐Razavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Borghei‐Razavi more than expected).

Fields of papers citing papers by Hamid Borghei‐Razavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamid Borghei‐Razavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Borghei‐Razavi. The network helps show where Hamid Borghei‐Razavi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hamid Borghei‐Razavi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hamid Borghei‐Razavi Line = papers co-authored together Hamid Borghei‐Razavi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20234
2 202211
3 20214
4 20215
5 20214
6 20211
7 20203
8 202042
9 20201
10 202017
11 20202
12 202033
13 20206
14 201913
15 20195
16 201917
17 201819
18 20182
19 20176
20 201531

About Hamid Borghei‐Razavi

Hamid Borghei‐Razavi is a scholar working on Neurology, Genetics and Epidemiology, having authored 51 papers that have together received 452 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (30 papers), Head and Neck Surgical Oncology (19 papers), Neurofibromatosis and Schwannoma Cases (12 papers), Glioma Diagnosis and Treatment (10 papers), Vascular Malformations Diagnosis and Treatment (9 papers), Brain Metastases and Treatment (7 papers), Cerebrospinal fluid and hydrocephalus (7 papers) and Trigeminal Neuralgia and Treatments (7 papers). The work is most often cited by research in Neurology (184 citations), Genetics (116 citations) and Epidemiology (241 citations). Hamid Borghei‐Razavi has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Paul A. Gardner, Gene H. Barnett, Huy Truong, Kazunari Yoshida, Shunsuke Shibao, Carl H. Snyderman, Eric W. Wang, Alireza M. Mohammadi, Juan C. Fernandez‐Miranda and Badih Adada. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026